{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface",
    "dc:creator": [
        "NIO, Yoshinori",
        "HIRAHARA, Noriyuki",
        "MINARI, Yoshimitsu",
        "IGUCHI, Chikage",
        "YAMASAWA, Kunihiro",
        "TOGA, Tomoko",
        "TAMURA, Katsuhiro"
    ],
    "dc:relation": "Anticancer research -- Anticancer res, ISSN 0250-7005, Vol. 20 (5A) , pp. 3293-3299",
    "dc:date": "2000",
    "dc:type": [
        "Text",
        "Article"
    ],
    "dc:language": "English",
    "dc:publisher": "International Institute of Anticancer Research",
    "dc:format": [
        "print",
        "17 ref"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Hémopathie maligne"
        },
        {
            "@xml:lang": "fr",
            "#text": "Lymphoprolifératif syndrome"
        },
        {
            "@xml:lang": "fr",
            "#text": "Mammalia"
        },
        {
            "@xml:lang": "fr",
            "#text": "Rodentia"
        },
        {
            "@xml:lang": "fr",
            "#text": "Vertebrata"
        },
        {
            "@xml:lang": "fr",
            "#text": "Agent alkylant"
        },
        {
            "@xml:lang": "fr",
            "#text": "Animal"
        },
        {
            "@xml:lang": "fr",
            "#text": "Anticancéreux"
        },
        {
            "@xml:lang": "fr",
            "#text": "Antigène histocompatibilité classe I"
        },
        {
            "@xml:lang": "fr",
            "#text": "Chimiothérapie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Cisplatine"
        },
        {
            "@xml:lang": "fr",
            "#text": "Lignée cellulaire établie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Modèle animal"
        },
        {
            "@xml:lang": "fr",
            "#text": "Plasmocytome"
        },
        {
            "@xml:lang": "fr",
            "#text": "Platine II Complexe"
        },
        {
            "@xml:lang": "fr",
            "#text": "Réponse immune"
        },
        {
            "@xml:lang": "fr",
            "#text": "Souris"
        },
        {
            "@xml:lang": "fr",
            "#text": "Système H-2"
        },
        {
            "@xml:lang": "fr",
            "#text": "Système histocompatibilité majeur"
        },
        {
            "@xml:lang": "fr",
            "#text": "Traitement"
        },
        {
            "@xml:lang": "fr",
            "#text": "Lignée MOPC 104E"
        },
        {
            "@xml:lang": "en",
            "#text": "Malignant hemopathy"
        },
        {
            "@xml:lang": "en",
            "#text": "Lymphoproliferative syndrome"
        },
        {
            "@xml:lang": "en",
            "#text": "Mammalia"
        },
        {
            "@xml:lang": "en",
            "#text": "Rodentia"
        },
        {
            "@xml:lang": "en",
            "#text": "Vertebrata"
        },
        {
            "@xml:lang": "en",
            "#text": "Alkylating agent"
        },
        {
            "@xml:lang": "en",
            "#text": "Animal"
        },
        {
            "@xml:lang": "en",
            "#text": "Antineoplastic agent"
        },
        {
            "@xml:lang": "en",
            "#text": "Class I histocompatibility antigen"
        },
        {
            "@xml:lang": "en",
            "#text": "Chemotherapy"
        },
        {
            "@xml:lang": "en",
            "#text": "Cisplatin"
        },
        {
            "@xml:lang": "en",
            "#text": "Established cell line"
        },
        {
            "@xml:lang": "en",
            "#text": "Animal model"
        },
        {
            "@xml:lang": "en",
            "#text": "Plasmacytoma"
        },
        {
            "@xml:lang": "en",
            "#text": "Platinum II Complexes"
        },
        {
            "@xml:lang": "en",
            "#text": "Immune response"
        },
        {
            "@xml:lang": "en",
            "#text": "Mouse"
        },
        {
            "@xml:lang": "en",
            "#text": "H-2-System"
        },
        {
            "@xml:lang": "en",
            "#text": "Major histocompatibility system"
        },
        {
            "@xml:lang": "en",
            "#text": "Treatment"
        },
        {
            "@xml:lang": "es",
            "#text": "Hemopatía maligna"
        },
        {
            "@xml:lang": "es",
            "#text": "Linfoproliferativo síndrome"
        },
        {
            "@xml:lang": "es",
            "#text": "Mammalia"
        },
        {
            "@xml:lang": "es",
            "#text": "Rodentia"
        },
        {
            "@xml:lang": "es",
            "#text": "Vertebrata"
        },
        {
            "@xml:lang": "es",
            "#text": "Agente alquilante"
        },
        {
            "@xml:lang": "es",
            "#text": "Animal"
        },
        {
            "@xml:lang": "es",
            "#text": "Anticanceroso"
        },
        {
            "@xml:lang": "es",
            "#text": "Antígeno histocompatibilidad clase I"
        },
        {
            "@xml:lang": "es",
            "#text": "Quimioterapia"
        },
        {
            "@xml:lang": "es",
            "#text": "Cisplatino"
        },
        {
            "@xml:lang": "es",
            "#text": "Línea celular establecida"
        },
        {
            "@xml:lang": "es",
            "#text": "Modelo animal"
        },
        {
            "@xml:lang": "es",
            "#text": "Plasmocitoma"
        },
        {
            "@xml:lang": "es",
            "#text": "Platino II Complejo"
        },
        {
            "@xml:lang": "es",
            "#text": "Respuesta inmune"
        },
        {
            "@xml:lang": "es",
            "#text": "Ratón"
        },
        {
            "@xml:lang": "es",
            "#text": "Sistema H-2"
        },
        {
            "@xml:lang": "es",
            "#text": "Sistema histocompatibilidad mayor"
        },
        {
            "@xml:lang": "es",
            "#text": "Tratamiento"
        },
        "002B02R02: Chimiothérapie / Chemotherapy"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 1526780"
}